Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 3, 2024
Improving Intravenous and Subcutaneous Insulin Overlap During Treatment of Diabetic Ketoacidosis: A Quality Improvement ProjectAndrew A Welch, David Toro-Tobon, Kharisa N Rachmasari, et al.
The Lancet. Diabetes & Endocrinology|October 16, 2020
Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort studyAndreas Ebbehoj, Dingfeng Li, Ravinder J Kaur, et al.
Mededportal : the Journal of Teaching and Learning Resources|January 6, 2025
Student-Led Medical Mandarin Summer Course for Medical Students With Existing Mandarin FluencyWhitney Li, Vicki Wang, Yuwen Jian, et al.
Plos One|June 12, 2025
The optimal warming strategy to reduce perioperative hypothermia: A prospective randomized non-blinded clinical trialRonak Desai, Jason Gosschalk, Noud van Helmond, et al.
Journal of Hematology & Oncology|October 12, 2025
Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activityYan-Ruide Li, Xinyuan Shen, Yichen Zhu, et al.
Research (Washington, D.C.)|June 15, 2026
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural MesotheliomaYan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2025
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safetyYan-Ruide Li, Yichen Zhu, Zhe Li, et al.
Science (New York, N.Y.)|April 24, 2025
Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunityDavid Kung-Chun Chiu, Xiangyue Zhang, Bowie Yik-Ling Cheng, et al.
Nature Communications|February 9, 2026
A generic reference defined by consensus peaks for single-cell ATAC-seq data analysisQiuchen Meng, Xinze Wu, Wenchang Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studiesChristopher R Calabrese, Michael A Batey, Huw D Thomas, et al.
Pageof 4